New Blood Test Shows High Accuracy in Early Detection of Pancreatic Cancer

A groundbreaking study reveals a blood test capable of detecting early-stage pancreatic cancer with up to 97% accuracy, offering hope for earlier interventions.

• A new blood test, when combined with an established cancer marker, can detect early-stage pancreatic cancers with up to 97% accuracy.
• The test identifies a genetic 'signature' of pancreatic cancer by analyzing small RNA particles and larger DNA markers.
• Early detection is crucial as the five-year survival rate for early-stage pancreatic cancer is significantly higher than that of advanced stages.
• The test's effectiveness was demonstrated in a trial involving over 900 participants from the U.S., Japan, South Korea, and China.
• Further research is needed to validate the test for general population use, but the findings are considered a significant step forward in the fight against pancreatic cancer.

3 Articles

UPI CNN Stat News